CASI PHARMACEUTICALS, INC. Interest Expense
CASI PHARMACEUTICALS, INC. (CASIF) reported Interest Expense of $0 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2023-04-26
| Period end | Interest Expense 12 month |
|---|---|
| 2022-12-31 | $0.00 20-F · filed 2023-04-26 |
| 2021-12-31 | $2.90K 20-F · filed 2023-04-26 |
| 2020-12-31 | $3.10K 20-F · filed 2023-04-26 |